Luisa Franzini

Luisa Franzini

Auto-generated profile, based on publicly available information

Luisa Franzini

Department of Health Policy and Management, School of Public Health, University of Maryland, College Park, Maryland, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Pain Medicine
Verified
Journal Article
Open access
PDF file
SGSantosh Gautam
Santosh Gautam
LFLuisa Franzini
Luisa Franzini
OMOsama I. Mikhail
Osama I. Mikhail
WCWenyaw Chan
Wenyaw Chan
BTBarbara J. Turner
Barbara J. Turner
Objective. To examine associations of opioid analgesic dose with quality of care for diabetes mellitus.Design. Longitudinal statewide cohort.Subjects.

8 February 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
JKJunghyun Kim
Junghyun Kim
SRSuja S. Rajan
Suja S. Rajan
XDXianglin L. Du
Xianglin L. Du
LFLuisa Franzini
Luisa Franzini
SGSharon H. Giordano
Sharon H. Giordano
RMRobert O. Morgan
Robert O. Morgan

1 January 2008 in Journal of Medical Economics
Verified
Journal Article
Open access
LFLuisa Franzini
Luisa Franzini
ETEric Thomas
Eric Thomas
(2008). Costs and effectiveness of tele-ICUs in reducing morbidity and mortality in intensive care units. Journal of Medical Economics: Vol. 11, No. 1, pp. 165-169. doi: 10.3111/13696990801967493

6 July 2024 in Military Medicine
Verified
Journal Article
Open access
PDF file
AEAmber El-Amin
Amber El-Amin
TKTracey Koehlmoos
Tracey Koehlmoos
DYDahai Yue
Dahai Yue
JCJie Chen
Jie Chen
NCNam Yong Cho
Nam Yong Cho
LFLuisa Franzini
Luisa Franzini
Introduction: Congenital heart disease (CHD) is the most common and resource demanding birth defect managed in the United States, with approximately 40,000 children undergoing CHD surgery year. Researchers have compared high-volume to low-volume hospitals and found significant hospital-level variation in major complications, health resource utilization, and health care costs after CHD surgery. Materials and Methods: Using nationwide representative claim data from the United States Military Health System from 2016 to 2020, TRICARE beneficiaries diagnosed with CHD were tabulated based on ICD-10 codes (International Classification of Diseases, 10th revision). We examined the relationships between total costs and total hospitalizations costs post 1-year CHD diagnosis and presence or absence of High-Quality Hospital (HQH) designation. We applied both the naive generalized linear model (GLM) to control for the observed patient and hospital characteristics and the 2-stage least squares (2SLS) model to account for the unobserved confounding factors. This study was approved by University of Maryland, College Park Institutional Review Board (IRB) (Approval Number: 1576246-2). Results: A relationship between HQH designation and total CHD related costs was not seen across 2SLS model specifications (marginal effect; −$41,579; 95% CI, −$83,429 to $271). For patients diagnosed with a moderate-complex or single ventricle CHD, the association of HQH status was a statistically significant reduction in total costs (marginal effect; −$84,395; 95% CI, −$140,560 to −$28,229) and hospitalization costs (marginal effect; −$73,958; 95% CI, −$121,878 to −$26,039). Conclusions: It is very imperative for clinicians and patient support advocates to urge policymakers to deliberate the establishment of a quality designation authority for CHD management. These efforts will not only help to identify and standardize quality care metrics but to improve long-term health, effectiveness, and equity in the management of CHD. Furthermore, these efforts can be used to navigate patients to proven HQH, thereby improving care and reducing associated treatment costs for CHD patients.

21 November 2025 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Closed access
PTPallavi Tyagi
Pallavi Tyagi
LFLuisa Franzini
Luisa Franzini
JCJie Chen
Jie Chen
Background: Preclinical Mobility Limitations (PCML) represent an early transitional stage in which individuals compensate for functional decline, yet do not exhibit overt disability. Recognition of PCML may identify individuals at elevated risk for future disability. Despite its importance, PCML has been understudied using nationally representative datasets. The purpose of this study is to operationalize and validate PCML using the National Health and Aging Trends Study (NHATS) and to examine its prevalence among community dwelling older adults. Methods: We analyzed 4,566 participants from NHATS 2022/2023. PCML was operationalized based on expert consensus, incorporating task modifications and reduction in frequency of tasks without overt difficulty. We examined the prevalence of PCML and its association with sociodemographic and health factors. Concurrent validity was assessed using the Short Physical Performance Battery (SPPB) measure and an assessment of participation restrictions. We evaluated whether PCML predicts incident manifest limitations one year later using logistic multivariate regression models. Results: PCML was identified in 46.8% of older adults and was more prevalent among those that were between the ages of 75-84 years and women. The mean SPPB composite score for those with PCML was 9.7 out of 12 and 30.6% reported participation restrictions. Those with PCML had 1.8 times increased odds of developing manifest limitations within one year, compared to those without PCML. Conclusions: This PCML measure has strong criterion validity, highlighting its utility as an early marker of functional decline. Screening for PCML in primary care may provide opportunities to prevent mobility disability and improve quality of life among older adults.

14 February 2024 in Military Medicine
Verified
Journal Article
Closed access
PDF file
AEAmber El-Amin
Amber El-Amin
TKTracey Koehlmoos
Tracey Koehlmoos
DYDahai Yue
Dahai Yue
JCJie Chen
Jie Chen
NCNam Yong Cho
Nam Yong Cho
LFLuisa Franzini
Luisa Franzini
Congenital heart disease (CHD) has an incidence of 0.8% to 1.2% worldwide, making it the most common birth defect. Researchers have compared high-volume to low-volume hospitals and found significant hospital-level variation in major complications, health resource utilization, and mortality after CHD surgery. In addition, researchers found critical CHD patients at low-volume/non-teaching facilities to be associated with higher odds of inpatient mortality when compared to CHD patients at high-volume/teaching hospitals (odds ratio 1.76). We examined the effects of high-quality hospital (HQH) use on health care outcomes and health care costs in pediatric CHD care using an instrumental variable (IV) approach. Using nationwide representative claim data from the United States Military Health System from 2016 to 2020, TRICARE beneficiaries with a diagnosis of CHD were tabulated based on relevant ICD-10 (International Classification of Diseases, 10th revision) codes. We examined the relationships between annual readmissions, annual emergency room (ER) use, and mortality and HQH use. We applied both the naive linear probability model (LPM), controlling for the observed patient and hospital characteristics, and the two-stage least squares (2SLS) model, accounting for the unobserved confounding factors. The differential distance between the patient and the closest HQH at the index date and the patient and nearest non-HQH was used as the IV. This protocol was approved by the Institutional Review Board at the University of Maryland, College Park (Approval Number: 1576246-2). The naive LPM indicated that HQH use was associated with a higher probability of annual readmissions (marginal effect, 18%; 95% CI, 0.12 to 0.23). The naive LPM indicated that HQH use was associated with a higher probability of mortality (marginal effect, 2.2%; 95% CI, 0.01 to 0.03). Using the differential distance of closest HQH and non-HQH, we identified a significant association between HQH use and annual ER use (marginal effect, −14%; 95% CI, −0.24 to −0.03). After controlling for patient-level and facility-level covariates and adjusting for endogeneity, (1) HQH use did not increase the probability of more than one admission post 1-year CHD diagnosis, (2) HQH use lowered the probability of annual ER use post 1-year CHD diagnosis, and (3) HQH use did not increase the probability of mortality post 1-year CHD diagnosis. Patients who may have benefited from utilizing HQH for CHD care did not, alluding to potential barriers to access, such as health insurance restrictions or lack of patient awareness. Although we used hospital quality rating for congenital cardiac surgery as reported by the Society of Thoracic Surgeons, the contributing data span a 4-year period and may not reflect real-time changes in center performance. Since this study focused on inpatient care within the first-year post-initial CHD diagnosis, it may not reflect the full range of health system utilization. It is necessary for clinicians and patient advocacy groups to collaborate with policymakers to promote the development of an overarching HQH designation authority for CHD care. Such establishment will facilitate access to HQH for military beneficiary populations suffering from CHD.